Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
Status: SUSPENDED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Herceptin
Sponsor: National Guard Health Affairs